Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Feasibility of the WhiteSwell System for the Reduction of Interstitial Fluid Overload in Patients With Acutely Decompensated Heart Failure

NCT02863796 is registered in ClinicalTrials.gov with WhiteSwell, Limited as lead sponsor.

NCT NCT02863796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Feasibility of the WhiteSwell System for the Reduction of Interstitial Fluid Overload in Patients With Acutely Decompensated Heart Failure
Lead sponsor
WhiteSwell, Limited
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2016
Completion date
March 14, 2022
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, heart failure